These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10160262)

  • 1. Big future in store for biochemical bone markers.
    Titus K
    CAP Today; 1996 Feb; 10(2):5, 8. PubMed ID: 10160262
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone markers: biochemical and clinical significance.
    Lello S; Paoletti AM; Migliaccio S; Melis GB
    Aging Clin Exp Res; 2004 Jun; 16 Suppl(3):33-6. PubMed ID: 15506699
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical markers of bone turnover. I: Theoretical considerations and clinical use in osteoporosis.
    Delmas PD
    Am J Med; 1993 Nov; 95(5A):11S-16S. PubMed ID: 8256787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers of bone turnover: an update.
    van Daele PL; Birkenhäger JC; Pols HA
    Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of bone biochemical markers and its application for clinics].
    Nishijima R; Kamimiya F; Horiuchi T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():333-8. PubMed ID: 15035147
    [No Abstract]   [Full Text] [Related]  

  • 7. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological variation of biochemical bone markers.
    Jensen JE; Sørensen HA; Kollerup G; Jensen LB; Sørensen OH
    Scand J Clin Lab Invest Suppl; 1994; 219():36-9. PubMed ID: 7701238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical markers of bone turnover for treatment of osteoporosis].
    Fujiyama K; Kiriyama T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():256-62. PubMed ID: 11979917
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice?
    Blumsohn A; Eastell R
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():449-59. PubMed ID: 9293302
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of osteoporosis by using biochemical markers for bone turnover].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():227-30. PubMed ID: 18159710
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
    Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
    Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis.
    Delmas PD
    Am J Med; 1991 Nov; 91(5B):59S-63S. PubMed ID: 1750421
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laboratory tests and bone biopsy in the diagnosis and treatment of osteoporosis].
    Burckhardt P
    Rev Med Suisse Romande; 1982 Jun; 102(6):599-605. PubMed ID: 7134717
    [No Abstract]   [Full Text] [Related]  

  • 16. Using biochemical bone markers.
    Chapman B
    CAP Today; 1997 Feb; 11(2):1, 30-2, 36. PubMed ID: 10166427
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of the new biochemical markers of bone metabolism].
    Rodríguez Espinosa J; Queraltó Compañó JM
    Med Clin (Barc); 1998 Sep; 111(7):259-62. PubMed ID: 9789241
    [No Abstract]   [Full Text] [Related]  

  • 18. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers used in the diagnosis and monitoring of osteoporosis.
    Bollerslev J
    Scand J Clin Lab Invest Suppl; 1994; 219():33-5. PubMed ID: 7701237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.